Sodium hydride → 10-Chloro-6-methyl-2-[(2-methyl-1,3-thiazol-4-yl)methyl]-2,6,9,11-tetrazabicyclo[5.4.0]undeca-7,9,11-trien-5-one

HRID 2234404

반응식

HRID 2234404 반응식
[H-].[Na+].[Cl:3][C:4]1[N:14]=[C:13]2[C:7]([N:8]([CH3:16])[C:9](=[O:15])[CH2:10][CH2:11][NH:12]2)=[CH:6][N:5]=1.Cl[CH2:18][C:19]1[N:20]=[C:21]([CH3:24])[S:22][CH:23]=1>CC(N(C)C)=O>[Cl:3][C:4]1[N:14]=[C:13]2[C:7]([N:8]([CH3:16])[C:9](=[O:15])[CH2:10][CH2:11][N:12]2[CH2:18][C:19]2[N:20]=[C:21]([CH3:24])[S:22][CH:23]=2)=[CH:6][N:5]=1

참가 물질

5

반응물 3

HCID 24758Sodium hydrideHCID 7363414-(Chloromethyl)-2-methyl-1,3-thiazoleHCID 866175762-Chloro-5-methyl-5,7,8,9-tetrahydro-6H-pyrimido[4,5-b][1,4]diazepin-6-one2회

생성물 1

HCID 8661757710-Chloro-6-methyl-2-[(2-methyl-1,3-thiazol-4-yl)methyl]-2,6,9,11-tetrazabicyclo[5.4.0]undeca-7,9,11-trien-5-one

시약·촉매·용매 1

HCID 31374Dimethylacetamide용매2회

실험 절차

To a cooled (ice/water bath) suspension of sodium hydride (60% dispersion in mineral oil; 13 mg, 0.38 mmol) in DMA (0.5 mL) was added a solution of 10-chloro-6-methyl-2,6,9,11-tetrazabicyclo[5.4.0]undeca-7,9,11-trien-5-one (Intermediate 100; 63 mg, 0.30 mmol) in DMA (1 mL). The reaction mixture was allowed to stir, under nitrogen, in ice bath for 10 minutes prior to addition of 4-chloromethyl-2-methylthiazole (ASDI; 75 mg, 0.51 mmol). The reaction mixture was stirred in an ice bath for 20 minutes and then warmed to ambient temperature over 1 hour.

후처리

  1. temperatureTo a cooled
  2. stirringThe reaction mixture was stirred in an ice bath for 20 minutes

출처 및 근거

ORD 기록
ord-605d1fee3d894f2da07619cd6fce01f8
출처 데이터셋
uspto-grants-2010_05
특허 번호
US07709471B2

연결된 노트

불러오는 중…